Dolutegravir intermediate-1

Dolutegravir intermediate-1 is a synthetic intermediate of Dolutegravir extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV) -1 infection.

Product Specifications

CAS Number

[1335210-23-5]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

HIV

Type

Reference compound

Related Pathways

Anti-infection

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/Dolutegravir_intermediate-1.html

Purity

99.97

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(C1=C(OC)C(C(C(O)=O)=CN1CC(OC)OC)=O)OC

Molecular Formula

C13H17NO8

Molecular Weight

315.28

Precautions

H302, H315, H319, H335

References & Citations

[1]Sivaram Prasad, et al. Process for the preparation of dolutegravir . WO 2016125192 A2.

Shipping Conditions

Room Temperature

Storage Conditions

Store at room temperature, keep dry and cool

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

HIV-1

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

KN400505 1 Kit

ALDH2 Human Gene Knockout Kit (CRISPR)

Ask

View Details

GTR15269793 1 Vial

Lentiviral mouse Cdk11b shRNA (UAS) - Lentiviral mouse Cdk11b shRNA (UAS, GFP) (100)

Ask

View Details

P503843 100 µg

FCGRT & B2M Heterodimer Protein (C-His, Human)

Ask

View Details

MBS9355576-01 48 Well

Rat MAP Kinase-Activated Protein Kinase 5 (MAPKAPK5) ELISA Kit

Ask

View Details

MBS9355576-02 96 Well

Rat MAP Kinase-Activated Protein Kinase 5 (MAPKAPK5) ELISA Kit

Ask

View Details

MBS9355576-03 5x 96 Well

Rat MAP Kinase-Activated Protein Kinase 5 (MAPKAPK5) ELISA Kit

Ask

View Details